NUVISAN The Science CRO
Dr. Lena Steppe currently works as a Proposal Manager & BD Manager DMPK/Tox at NUVISAN The Science CRO. Prior to their current role, Dr. Lena was a Postdoctoral Researcher at Universität Ulm, where Dr. Lena also completed their doctoral studies in Molekulare Medizin. Dr. Lena holds a Bachelor of Science in Molekulare Medizin, a Master of Science in Biochemie, and a Doctorate in Molekulare Medizin from Ulm University. Additionally, Dr. Lena conducted their Master Thesis at Universitätsklinikum Ulm, focusing on Molecular Virology.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.